Dea Sik Kim

8PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyHaematologyNuclear medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 06, 2024
Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma.

Jun Ho Yi, Seok Jin Kim, Deok-Hwan Yang

|Jul 06, 2023
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma.

Junghoon Shin, Ji Yun Lee, Gyeong-Won Lee

|Apr 20, 2023
Implications of the 5th Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia.

Cheonghwa Lee, Ha Nui Kim, Jung Ah Kwon

|Jan 08, 2022
Peripheral T cell lymphoma of the nasopharynx with expansion of EBV-positive B cells masquerading as an extranodal NK/T cell lymphoma, nasal type.

Han-Na Kim, Dae Sik Kim, Min Ji Jeon

|May 30, 2020
Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia.

Seung Shin Lee, Sung Hoon Jung, Young Rok Do

|Jul 09, 2019
Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma.

Yong Park, Dae Sik Kim, Min Ji Jeon

Pageof 2

Frequent Collaborators

2 joint publications

Dong Gyu Na

2 joint publications

Soo Jin Kim

2 joint publications

Chul-Won Choi

2 joint publications

Eun Sang Yu